PSI Newsletter 2024

Read the updates and insights in the PSI Newsletter: Issue 3, 2024

• Commencement of Patient Safety Act 2023 and rollout of National Open Disclosure Framework 
• Expansion of pharmacy services – changes coming in 2025 and beyond 
• Codeine Specialist Surveyor Report 2024 published 
• Introduction of the National Veterinary Prescription System (NVPS) 
• Continued registration reminder 
• Pharmacy Practice update on the Administration of Injectable Medicines 
• Reminder: Prescriptions can now be valid for up to 12 months 
• Workforce Intelligence Employee Employer Forum
•  Fitness to Practise and Mediation Outcomes 
• Ideas for Training and Development for Pharmacists in 2025? 
• Importance of notifying pharmacy governance role vacancies 
• Ensuring compliance with FMD requirements 
• Learning more about the Windsor Framework and FMD
• Highlight AMR in your pharmacy this November 
• Digital transformation at the PSI 

Read the updates and insights in the PSI Newsletter: Issue 2, 2024

• PSI Guidelines to support prescription extension by pharmacists and updates on the Expert Taskforce 
• Update your practice area to improve Workforce Planning Data 
• Registration requirements for online sale of non-prescription medicines from pharmacies 
• New updates - HSE antibiotic prescribing website
• Topiramate (Topamax) & Valproate (Epilim) – updated HPRA materials
• Understanding the NIS2 Directive and its impact on pharmacies 
• ePortfolio Review 2024/2025
• Discover the new PSI Website 
• Learning from an inquiry
• Fitness to Practise and Mediation Outcomes 
• Public Consultation on PSI's Draft Corporate Strategy 2025-2028 
• Covid-19 Spring Booster Campaign update 
• Upcoming Webinars on Prescription Extension for Pharmacists

Read the updates and insights in the PSI Newsletter: Issue 1, 2024

• Expert Taskforce to support the expansion of the role of pharmacists in Ireland
• Prescription validity extended up to 12 months
• Changes to legislation impacting emergency supply of medicines including controlled drugs
• Antimicrobial resistance and stewardship – resources for pharmacists and the public
• HPRA Medicines Safety Updates: Valproate and Topiramate
• Effective counselling on prescribed medicines to enhance patient understanding
• Spring COVID-19 Booster Campaign – Updates to Training Modules
• Safe sales of paracetamol in pharmacy settings: Upcoming survey
• Call for Expressions of Interest from community pharmacists and their teams to participate in an in-pharmacy photoshoot for the PSI
• Learning from an Inquiry
• Fitness to Practise and Mediation Outcomes
• Nurse prescribers authorised to prescribe Lisdexamfetamine
• Coming soon: New PSI website
• PSI roadshows events: Resources